维生素D补充剂对糖尿病足愈合的影响:一个元分析
Xiaokun Wu1, Jinchan Zeng2, Xuemei Ye3
1Department of Nursing, Foshan Hospital of Traditional Chinese Medicine, 6 Qinren Road, Chancheng District, Foshan 528099, China.
Postgraduate medical journal
|August 31, 2024
概括
维生素D补充剂通过降低血糖和减轻炎症和氧化应激,显著改善糖尿病足 (DFU) 的愈合. 这一元分析提供了维生素D的证据.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 伤口治愈研究研究 伤口治愈研究
背景情况:
- 糖尿病足 (DFU) 是糖尿病的一个严重并发症.
- 维生素D在葡萄糖代谢,胰岛素敏感性和抗炎过程中发挥作用.
- 现有的关于维生素D用于DFU治疗的研究缺乏全面的整合.
研究的目的:
- 系统地审查和元分析维生素D补充剂对糖尿病足愈合的影响.
主要方法:
- 在多个数据库 (PubMed,科学网等) 进行了系统的文献搜索. 在2022年11月之前.
- 包括7项随机对照试验 (RCT),涉及580名患者.
- 数据提取,偏差风险评估和元分析使用RevMan 5.3软件进行.
主要成果:
- 维生素D补充剂显著提高了DFU患者的伤口愈合效率和减伤率.
- 它导致伤口面积,HbA1c,空腹胰岛素,HOMA-β,hs-CRP和ESR的显著减少.
- 氧化和甲水平有所改善,这表明氧化应激减少.
结论:
- 维生素D补充剂对DFU愈合有显著的积极影响.
- 该机制涉及改善葡萄糖代谢,减少炎症和减轻氧化应激.
- 这些发现为治疗DFU患者的临床医生提供了参考.
相关概念视频
01:25Role of Vitamins in Maintaining Bone Health
3.2K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.2K
01:23Dipeptidyl Peptidase 4 Inhibitors
178
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
178